Detalles de la búsqueda
1.
Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA.
Lancet
; 402(10419): 2307-2316, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37979595
2.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 402(10404): 775-785, 2023 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516125
3.
Atogepant for the Preventive Treatment of Migraine.
N Engl J Med
; 385(8): 695-706, 2021 08 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407343
4.
Health care resource utilization and costs associated with diagnosed medication overuse headache and potential acute medication overuse in individuals with migraine.
Cephalalgia
; 44(2): 3331024241235139, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410849
5.
Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex.
Cephalalgia
; 44(3): 3331024241238153, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38477313
6.
A multicenter, open-label long-term safety study of rimegepant for the acute treatment of migraine.
Cephalalgia
; 44(4): 3331024241232944, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38659334
7.
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults.
Cephalalgia
; 44(2): 3331024231219505, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366390
8.
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury.
Cephalalgia
; 44(3): 3331024241234068, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518177
9.
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial.
Eur J Neurol
; 31(2): e16131, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37955557
10.
A randomized, open-label, 5-period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and liquid nasal spray DHE in healthy adults.
Headache
; 64(3): 266-275, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413540
11.
Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi-country results from the CaMEO-I study.
Headache
; 64(5): 469-481, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38706199
12.
Prevalence and burden of migraine in the United States: A systematic review.
Headache
; 64(5): 516-532, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38700185
13.
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine.
Headache
; 64(2): 156-171, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235605
14.
Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study.
Headache
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38785227
15.
Personality predictors of dementia diagnosis and neuropathological burden: An individual participant data meta-analysis.
Alzheimers Dement
; 20(3): 1497-1514, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38018701
16.
Psychosocial factors associated with 7-year change in cognition among middle-aged and older Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA) and Sociocultural ancillary studies.
Alzheimers Dement
; 20(2): 1137-1148, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897802
17.
Connections between reproductive health and cognitive aging among women enrolled in the HCHS/SOL and SOL-INCA.
Alzheimers Dement
; 20(3): 1944-1957, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160447
18.
Lifestyle and incident dementia: A COSMIC individual participant data metaanalysis.
Alzheimers Dement
; 2024 Apr 27.
Artículo
en Italiano
| MEDLINE | ID: mdl-38676366
19.
Sustained response to atogepant in episodic migraine: post hoc analyses of a 12-week randomized trial and a 52-week long-term safety trial.
J Headache Pain
; 25(1): 83, 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38773375
20.
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.
J Headache Pain
; 25(1): 4, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38178049